Back To Schedule
Wednesday, June 27 • 10:30am - 11:45am
#336: Addressing the Elephant in the Room: A Hard Look at Metrics, Legal, Payers, and Other Leading Obstacles Facing the Sustainability of Patient Engagement

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-645-L04-P; CME 1.25; IACET 1.25; RN 1.25

As the industry continues to evolve and incorporate the patient’s voice into drug development - ultimately toward the stage of regular and continuous integrative collaboration - this session will discuss how it’s essential to openly assess and discuss common topics and challenges that may impact the long-term sustainability of patient engagement.

Learning Objectives

Identify the needs of private payers when defining the value of healthcare treatments and interventions; Describe the legal, regulatory, and compliance considerations that biopharmaceutical companies must address to develop and execute sustainable, ethical and compliant patient engagement initiatives; Evaluate methodologies that biopharmaceutical companies are using to measure internal changes related to regularly, efficiently, and successfully implementing patient-centric solutions.


Katherine Capperella


Industry Perspective
Rebecca A. Vermeulen, RPh

Patient Perspective
Jayne C. Gershkowitz

Legal Perspective
Patrik Florencio, JD

Payer Perspective
Samuel R. Nussbaum, MD

avatar for Katherine Capperella

Katherine Capperella

Global Patient Engagement Leader, Janssen Pharmaceutical Companies of Johnson & Johnson
As global head of Patient Engagement, Katherine leads a cross-functional team responsible for developing and driving patient engagement strategy and measuring progress over time. She is focused on leading Janssen to incorporate direct patient voice early and throughout the entire... Read More →
avatar for Patrik Florencio

Patrik Florencio

Senior Vice President, Global Chief Compliance and Risk Officer, Amicus Therapeutics
Patrik Florencio is SVP, Chief Compliance & Risk Officer at Amicus Therapeutics. Prior to Amicus, he held positions as Chief Compliance Officer of NPS Pharmaceuticals and Sandoz Inc. Previously, Mr. Florencio practiced health law at the law firm of Ropes & Gray. Mr. Florencio graduated... Read More →

Jayne Gershkowitz

Chief Patient Advocate, Amicus Therapeutics
avatar for Samuel Nussbaum

Samuel Nussbaum

Strategic Consultant, EBG Advisors, Inc.
Sam Nussbaum advises health care companies, health care systems and provider organizations; and serves on boards of directors and on policy organizations. He is a Senior Fellow at the Schaeffer Center for Health Policy and Economics at USC. His career has encompassed basic and clinical... Read More →
avatar for Rebecca Vermeulen

Rebecca Vermeulen

Head, Customer Strategy Global Medical Affairs, Hoffmann-La Roche Ltd.
Rebecca Vermeulen, RPh, brings a variety of experiences to her role as Customer Strategy and Patient Partnership for Global Medical Affairs at Roche. She has served in numerous functions including Medical Affairs, Clinical Research, Sales, Medical Communications, Medical Science Liaisons... Read More →

Wednesday June 27, 2018 10:30am - 11:45am EDT
Room 153ABC Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  05: Patient Engagement, Forum